Search

Displaying results 6811 - 6820 of 10000 in total
  1. Drug

    Tigemocoxib

    go.drugbank.com/drugs/DB21699
    Experimental

    The usage of the INN stem '-coxib' in the name indicates that Tigemocoxib is a selective cyclo-oxygenase inhibitor. Tigemocoxib has a monoisotopic molecular weight of 334.06 Da.

  2. Drug

    FRAX1036

    go.drugbank.com/drugs/DB31834
    Experimental

    FRAX1036 is a p21-activated kinase (PAK) inhibitor.

  3. Drug

    PF-4191834

    go.drugbank.com/drugs/DB11645
    Investigational

    PF-4191834 has been investigated for the basic science of Asthma.

  4. Drug

    Brivanib alaninate

    go.drugbank.com/drugs/DB11865
    Investigational

    Brivanib alaninate has been investigated for the treatment of Colorectal Cancer.

  5. Drug

    Ezutromid

    go.drugbank.com/drugs/DB12888
    Investigational

    Ezutromid has been investigated for the treatment of Muscular Dystrophy, Duchenne.

  6. Drug

    GET-73

    go.drugbank.com/drugs/DB12928
    Investigational

    Get 73 has been investigated for the treatment of Alcohol Dependence.

  7. Drug

    Pentavalent Antimony

    go.drugbank.com/drugs/DB13047
    Investigational

    Pentavalent Antimony has been investigated for the treatment of Cutaneous Leishmaniasis.

  8. Drug

    Prulifloxacin

    go.drugbank.com/drugs/DB11892
    Investigational

    Prulifloxacin has been investigated for the treatment of Urinary Tract Infection.

  9. Drug

    VP-14637

    go.drugbank.com/drugs/DB12195
    Investigational

    MDT-637 has been investigated for the treatment of Drug Safety.

  10. Drug

    Tozadenant

    go.drugbank.com/drugs/DB12203
    Investigational

    Tozadenant has been investigated for the basic science of Cocaine Dependence.